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Movement disorders reveal Creutzfeldt-Jakob disease
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Human prion diseases are sometimes difficult to diagnose because few clinical features distinguish them reliably from other neurological disorders. a new study suggests that analysis of movement disorders might contribute to the clinical differentiation of sporadic Creutzfeldt-Jakob disease from alzheimer disease and dementia with lewy bodies.
like other human prion diseases, CreutzfeldtJakob disease (CJD) causes progressive cognitive dysfunction resulting in dementia. in addition, most patients experience a spectrum of neurological disturbances, including symptoms and signs of motor system dysfunction (for example, myoclonic jerks and ataxia). Differentiating CJD from other dementias is problematic and no well-characterized surrogate markers exist for the disease. However, edler and colleagues 1 recently determined the value of motor disturbances in the diagnosis of human prion diseases; the presence of ataxia and dysmetria, along with the absence of hypokinesia, suggested the presence of CJD rather than alzheimer disease (aD) or demetia with lewy bodies (DlB).
Pathogenic prions are misfolded molecules that can convert normal prion protein to the abnormally folded state, and this ability is thought to account for their infectious character. Prions cause a group of neuro logical diseases that affect humans and various animals. these diseases can be propa gated through iatrogenic transmission of the prion particles between individuals, or in experimental animal models through various routes of inoculation.
2 Prion diseases are rare compared with their most important differential diagnoses, namely, aD and lB. 3, 4 Despite considerable progress in understanding prion disease patho genesis, unequivocal establishment of the CJD diagnosis from clinical and laboratory features (Box 1) during a patient's lifetime has remained a challenge. the clinical triad of demen tia, ataxia, and myoclonus is con sidered characteristic of CJD. Diagnosis can also be circumstantially supported by eeG patterns referred to as 'triphasic complexes' , and by the detection of proteins (for example, neuron-specific enolase and 14-3-3 protein), 'leaked' from injured neurons, in the patient's cerebrospinal fluid. However, all the above surrogate markers have limited specificity for prion disease. Potential alternative surrogate markers do exist, but they remain to be fully evaluated. these markers include the enzyme α1-antichymotrypsin, which can be detected in increased amounts both in brain tissue and in the urine of prion -infected animals, 5 and the pathological prion protein (PrP sc ) itself. the detection of PrP sc in body fluidsin the form of PrP sc aggregates 6 or prion seeds 7 -is hoped to facilitate early diagnosis. 8, 9 of note, familial forms of human prion diseases are more readily diagnosed than sporadic variants, because they are invariably associated with mutations in the prion protein gene, PRNP, and can be easily detected by Dna sequencing. most prion diseases, however, occur sporadically; familial forms account for <10% of all cases.
in an attempt to address the diagnostic problems, edler and colleagues analyzed the data on clinical presentation of 143 patients who had been referred to the German surveillance unit for spongiform encephalopathies in Göttingen for the assessment of possible prion disease. 1 Given
news & views patients with aD or DlB were by no means representative of the phenotypes typi cally associated with these diseases. rather, they were subsets of patients who were suspected by the referring physicians of having CJD. therefore, with regard to differential diagnoses, edler's study characterizes the clinical phenotype of CJD in relation to atypi cal forms of aD and DlB. the motor pheno types were, unsurprisingly, modulated by the polymorphism at codon 129 of the PRNP gene, because this important switch controls many other features of prion diseases, including susceptibility to infection and, in familial cases, the type of prion disease (that is, CJD versus fatal familial insomnia). 10 a future study to correlate the clinical phenotypes of the disease not only with genetic PRNP status, but also with biophysical charac teristics of the PrP sc aggregates might be of interest. these characteristics can be ascertained by nascent techniques, such as polythiophene fluorescence spectroscopy. 11 in conclusion, the edler et al. study provides a welcome improvement to the clinical characterization of CJD. the unmet medical challenge, however, is the necessity to develop reliable and sensitive diagnostic procedures to confirm the diagnosis of prion disease at the earliest possible stage during the patient's lifetime. the urgency of that quest stems not only from the enormous psychological implications of a tentative diagnosis of prion disease, but also from the incipient development of therapeutic agents that specifically target prion diseases over other types of illnesses that are characterized by dementia. 12 the rarity of prion diseases, this number of individuals represented a very large group. among those patients, 100 were confirmed to have CJD, 29 to have aD, 7 to have DlB, and 7 received other diagnoses. in the group of patients diagnosed as having CJD, the most common motor disturbances observed were gait disorders (80%), myoclonus (80%) and cerebellar ataxia (77%). Further analysis revealed that the presence of ataxia and dysmetria, along with the absence of hypo kinesia, suggested a diagnosis of CJD rather than one of aD or DlB. By contrast, pyramidal tract signs were associated with aD and DlB, but not with CJD. the very low incidence of prion disease compared with that of other diseases associated with these patterns of motor system dysfunction, however, means their predictive value for a diagnosis of CJD is limited.
a polymorphic site at codon 129 of the PRNP gene encodes either methionine or valine, and the allelic status of CJD patients modulates their clinical phenotype. the study suggests that among the 100 patients with CJD, ataxia and cogwheel rigidity were associated with valine homozygosity, whereas akinesia was associated with methionine homozygosity-although these associations were relatively weak.
edler and colleagues should be commended for their extensive analysis of the clinical features of sporadic CJD. an important point, however, is that the groups of 
